Anaplan, Inc. (NYSE:PLAN) tinted gains of +1.16% (+0.45 points) to US$39.18. The volume of 0.31 Million shares climbed down over an trading activity of 536.48 Million shares. EPS ratio determined by looking at last 12 month figures is -1.08. Over the same time span, the stock marked US$40.75 as its best level and the lowest price reached was US$20.37. The corporation has a market cap of US$4.81 Billion.
Anaplan, Inc. (NYSE:PLAN)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -42.3 percent. The company’s institutional ownership is monitored at 45.9 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 72 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 5 think it is Hold. Recently, analysts have updated the overall rating to 2.4. 4 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
IsoRay, Inc. (NYSE:ISR) is worth US$26.39 Million and has recently risen 1.6% to US$0.38. The latest exchange of 0.1 Million shares is below its average trading activity of 222.89 Million shares. The day began at US$0.38 but the price moved to US$0.38 at one point during the trading and finally capitulating to a session high of US$0.39. The stock tapped a 52-week high of US$1.22 while the mean 12-month price target for the shares is US$0.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 2.72, and a price to sales ratio of 4. For the past 5 years, the company’s revenue has grown 5.5%, while the company’s earnings per share has grown -1.6%. With an institutional ownership near 8.6%, it carries an earnings per share ratio of -0.11.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 2 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.